BIO is bringing together select Governors for a candid conversation about the impact of the life sciences industry in their respective states. The concentration of innovation and commercialization in the life sciences brings both challenges and opportunities. There are challenges associated with providing affordable access to innovative therapies; challenges in ensuring an aging population who requires more healthcare services, get those services; challenges in addressing the opioid crisis as we now face a decline in life expectancy among different segments of the population; and finally challenges in grappling with growing Medicaid budgets that are impinging on other state expenditures like education and transportation infrastructure. There are also great opportunities that come along with such a high concentration of the industry. There are opportunities in creating a talent pool of highly paid, highly skilled workers who are part of the technology economy; opportunities in nurturing companies that are developing cures for disease. This session will be moderated by renowned healthcare journalist, editor and policy expert Susan Dentzer. Join Susan as she leads a discussion with these three high-profile governors on varying issues important to the life sciences such as their responses to the nation’s opioid crisis, the impact rising healthcare costs have on state programs like Medicaid, and their efforts to nurture and grown the life sciences industry in their states. New findings from the BIO State Legislative Best Practices Report will be presented. This digest was created to assist biosciences industry partners and their economic development practitioners in identifying key state legislative and administrative efforts needed to create, nurture and retain the bioscience industry. The policies and legislation cited in this document are key examples of state efforts to grow and sustain bioscience industry development.